A significant portion of patients with multiple sclerosis (MS) can achieve a stable disease state when treated with modern disease-modifying therapy (DMT), especially when started early in the disease ...

Dr. Stephen Hauser was a young resident at Harvard when he met his first patient with multiple sclerosis, a woman with a thriving professional life who’d been completely wiped out by her condition, ...

JT Lew, PharmD, MBA, managed care pharmacist at MultiCare Health System, spoke to the impacts of processes such as prior authorization and step therapy requirements in the realm of multiple sclerosis ...

Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis. For years prior, she’d had severe fatigue, which a neurologist initially suspected was caused by ...

The first participant has been dosed in an investigator-led Phase 2 trial testing pegsebrenatide as a potential treatment for ...

STOCKHOLM ― Until their mid to late 30s, some people with multiple sclerosis (MS) can better compensate for damage to their central nervous system, new evidence suggests. Thereafter, at about age 40, ...

Multiple sclerosis (MS) is an autoimmune disease that destroys the protective myelin covering around nerves. Every five minutes, someone is diagnosed with the disease around the world, adding to about ...

A stem cell treatment commonly used for blood cancer appears effective in treating one form of MS The treatment has been available since the 1990s but questions about safety and difficulty have ...

This is Jayne Charles's third fundraiser for the Wolverhampton MS Therapy Centre.